177 related articles for article (PubMed ID: 19221623)
1. One grass or many? Does allergy distinguish among species?
Kleine-Tebbe J
Drugs Today (Barc); 2008 Dec; 44 Suppl B():65-7. PubMed ID: 19221623
[No Abstract] [Full Text] [Related]
2. Is intralymphatic immunotherapy ready for clinical use in patients with grass pollen allergy?
Witten M; Malling HJ; Blom L; Poulsen BC; Poulsen LK
J Allergy Clin Immunol; 2013 Nov; 132(5):1248-1252.e5. PubMed ID: 24035151
[No Abstract] [Full Text] [Related]
3. Clinical trial shows sublingual immunotherapy to be effective for treatment of children with grass pollen allergy.
Wilkinson J
Immunotherapy; 2012 Nov; 4(11):1091-2. PubMed ID: 23194357
[No Abstract] [Full Text] [Related]
4. Immunotherapy in hay fever with two major allergens 19, 25 and partially purified extract of timothy grass pollen. A controlled double blind study. In vitro variables, season i.
Osterballe O; Løwenstein H; Prahl P; Skov P; Weeke B
Allergy; 1981 Apr; 36(3):183-99. PubMed ID: 7015911
[No Abstract] [Full Text] [Related]
5. The effects of grass pollen allergoid immunotherapy on clinical and immunological parameters in children with allergic rhinitis.
Keskin O; Tuncer A; Adalioglu G; Sekerel BE; Saçkesen C; Kalayci O
Pediatr Allergy Immunol; 2006 Sep; 17(6):396-407. PubMed ID: 16925684
[TBL] [Abstract][Full Text] [Related]
6. Early improvement in basophil sensitivity predicts symptom relief with grass pollen immunotherapy.
Schmid JM; Würtzen PA; Dahl R; Hoffmann HJ
J Allergy Clin Immunol; 2014 Sep; 134(3):741-744.e5. PubMed ID: 24934275
[No Abstract] [Full Text] [Related]
7. Ultra-short-course booster allergen immunotherapy.
Pfaar O; Pieper-Fürst U; Mösges R
Immunotherapy; 2018 Jun; 10(7):525-528. PubMed ID: 29562789
[No Abstract] [Full Text] [Related]
8. Long-term immunological effects of Japanese cedar pollen-based subcutaneous immunotherapy.
Inuo C; Ando H; Tanaka K; Nakajima Y; Tsuge I; Urisu A; Kondo Y
Allergol Int; 2018 Jul; 67(3):408-410. PubMed ID: 29198713
[No Abstract] [Full Text] [Related]
9. Sublingual immunotherapy.
Frew AJ
N Engl J Med; 2008 May; 358(21):2259-64. PubMed ID: 18499568
[No Abstract] [Full Text] [Related]
10. Lolium perenne peptides for treatment of grass pollen allergy: A randomized, double-blind, placebo-controlled clinical trial.
Shamji MH; Ceuppens J; Bachert C; Hellings P; Placier G; Thirion G; Bovy N; Durham SR; Duchateau J; Legon T; Pirotton S
J Allergy Clin Immunol; 2018 Jan; 141(1):448-451. PubMed ID: 29030102
[No Abstract] [Full Text] [Related]
11. Grass pollen immunotherapy: where are we now.
Würtzen PA; Gupta S; Brand S; Andersen PS
Immunotherapy; 2016; 8(4):399-411. PubMed ID: 26973122
[TBL] [Abstract][Full Text] [Related]
12. [Sublingual immunotherapy in children with grass pollen induced allergic rhinoconjunctivitis].
Wolthers OD; Høst A; Frederiksen B; Halken S
Ugeskr Laeger; 2012 Aug; 174(35):1989-92. PubMed ID: 22929576
[TBL] [Abstract][Full Text] [Related]
13. [Hyposensitization with cross-reacting pollen allergens].
Karl S; Rakoski J
Z Hautkr; 1988; 63 Suppl 4():55-7. PubMed ID: 3252627
[TBL] [Abstract][Full Text] [Related]
14. SQ-standardised grass tablet sublingual immunotherapy: persistent clinical benefit and progressive immunological changes during three years treatment.
Durham SR
Arb Paul Ehrlich Inst Bundesinstitut Impfstoffe Biomed Arzneim Langen Hess; 2009; 96():121-7; discussion 127-31. PubMed ID: 20799452
[No Abstract] [Full Text] [Related]
15. Pretreatment IgE sensitization patterns determine the molecular profile of the IgG4 response during updosing of subcutaneous immunotherapy with timothy grass pollen extract.
Schmid JM; Würtzen PA; Dahl R; Hoffmann HJ
J Allergy Clin Immunol; 2016 Feb; 137(2):562-70. PubMed ID: 26141262
[TBL] [Abstract][Full Text] [Related]
16. Three-injection intralymphatic immunotherapy in adolescents and young adults with grass pollen rhinoconjunctivitis.
Patterson AM; Bonny AE; Shiels WE; Erwin EA
Ann Allergy Asthma Immunol; 2016 Feb; 116(2):168-70. PubMed ID: 26706294
[No Abstract] [Full Text] [Related]
17. Pre-seasonal, subcutaneous immunotherapy: a double-blinded, placebo-controlled study in elderly patients with an allergy to grass.
Bozek A; Kolodziejczyk K; Krajewska-Wojtys A; Jarzab J
Ann Allergy Asthma Immunol; 2016 Feb; 116(2):156-61. PubMed ID: 26815709
[TBL] [Abstract][Full Text] [Related]
18. Allergen-specific immunoprophylaxis: toward secondary prevention of allergic rhinitis?
Matricardi PM
Pediatr Allergy Immunol; 2014 Feb; 25(1):15-8. PubMed ID: 24588481
[No Abstract] [Full Text] [Related]
19. The clinical relevance of molecular diagnosis in children allergic to grass pollen and treated with allergen immunotherapy.
Barberi S; Traina G; Landi M; De Castro G; Peroni D; Licari A; Marseglia G; Ciprandi G
Allergol Immunopathol (Madr); 2019; 47(3):309-310. PubMed ID: 30738628
[No Abstract] [Full Text] [Related]
20. [Pollen-induced allergy. Programming and monitoring of specific immunotherapy].
Obtułowicz K
Folia Med Cracov; 1988; 29(1-2):21-48. PubMed ID: 3255656
[No Abstract] [Full Text] [Related]
[Next] [New Search]
